Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants

NCT00617071 | Unknown Phase 3

• 2 other identifiers: CDR0000584278TJUH-2006-44
• Study Type: interventional
• Target: 900
• Locations: 1 country
• Sites: 1

Brief Summary

RATIONALE: Developing a personalized screening plan may be more effective than usual care in increasing the number of healthy participants who regularly undergo screening for colorectal cancer. PURPOSE: This randomized phase III trial is studying personalized screening plans to see how well they work compared with usual care in increasing colorectal cancer screening in healthy participants.

Conditions

Colorectal Cancer

Keywords

colon cancer; rectal cancer

Outcome Measures

Primary Outcomes (1)

• Screening utilization over the 6-month observation period

Secondary Outcomes (4)

• Screening preference

• Perceived salience and coherence and self-efficacy related to colorectal cancer (CRC) screening

• Number and length of contacts with each participant and the type of communication during those contacts

• Identification of predictors of CRC screening use and screening preference

Interventions

medical chart review OTHER

survey administration OTHER

fecal occult blood test PROCEDURE

screening colonoscopy PROCEDURE

Eligibility Criteria

• Age: 50 Years - 74 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

DISEASE CHARACTERISTICS: * Meets the following criteria: * No personal history of colorectal neoplasia (cancer or polyps) or inflammatory bowel disease * No family history of colorectal cancer (CRC) diagnosed before the age of 60 * Visited one of the six community-based primary care practices that are part of the Christiana Care Health System (CCHS) in Delaware within the past 2 years * Not up-to-date with CRC screening, according to the United States Preventive Services Task Force guidelines PATIENT CHARACTERISTICS: * Must have a complete address and telephone number * Able to communicate in English * No psychosis or severe dementia PRIOR CONCURRENT THERAPY: * No prior participation in the developmental study CA10241

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

• Sidney Kimmel Cancer Center at Thomas Jefferson University: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

Kimmel Cancer Center at Thomas Jefferson University - Philadelphia

Philadelphia, Pennsylvania, 19107-5541, United States

RECRUITING

MeSH Terms

Conditions

Colorectal Neoplasms; Colonic Neoplasms; Rectal Neoplasms

Interventions

Occult Blood

Condition Hierarchy (Ancestors)

Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases

Intervention Hierarchy (Ancestors)

Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Investigative Techniques

Study Officials

• Ronald Myers, PhD

  Jefferson Medical College of Thomas Jefferson University

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: phase 3
• Allocation: RANDOMIZED
• Masking: SINGLE
• Purpose: HEALTH SERVICES RESEARCH
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: February 14, 2008
• First Posted: February 15, 2008
• Study Start: January 1, 2007
• Primary Completion: December 1, 2010
• Last Updated: December 18, 2013

Record last verified: 2009-07

Locations

US (1)